Wishlist (0)
Welcome visitor Login or Register.
My Cart    0 $0.00
Your shopping cart is empty!
Amuvatinib

Amuvatinib

0 reviews Write a review
Product Code: 3026
Availability: In Stock
$461.00
-+

Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Phase 2.

Chemical Name:N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

Inhibitors Protein Tyrosine Kinase c-Kit Amuvatinib 850879-09-3
Biological Activity:
Biological Activity Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Phase 2.
Technical Data:
M.W. 447.51
Formula: C<sub>23</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>S
Solubility: DMSO
Purity: 98%
Storage: -20℃
CAS No: 850879-09-3
References:
References Bearss DJ, et al. US Patent, US/2008/0226747. Hurley LH, et al. World Patent, WO/2005/037825. Mahadevan D, et al. Oncogene, 2007, 26(27), 3909-3919. Qi W, et al. BMC Cancer, 2009, 9, 142. Welsh JW, et al. Radiat Oncol, 2009, 4, 69. Zhao H, et al. Radiother Oncol, 2011, 101(1), 59-65.

Write a review

Note: HTML is not translated!
    Bad           Good
Continue

About HDH PHARMA

At HDH Pharma, we are committed to offering our clients the highest quality research services with the most convenient and effective communications from both US and Indian operations. Clients in the Americas and Europe can pick up the phone and speak directly with our scientists in the US. Clients in Asia can receive the same rapid response from our scientists in India. HDH’s hybrid operation is designed with our client’s operational needs in mind.


Information

Extras

My Account

Powered By Nsoft Solutions
HDH PHARMA © 2024